Delving into the Latest Updates on Verthermia Acquisition, Inc. with Synapse

Overview

An elderly female with failed third-line peritoneal serous papillary carcinoma with metastasis (ovarian cancer) was treated by our proprietary method of whole-body hyperthermia-a recirculating extracorporeal circuit at 42°C for 120 minutes. She received six cycles, 28 days apart. Five index lesions were measured prior to and after each treatment. Results showed stable disease with reduced standard uptake volume. She then restarted six cycles of a previously failed chemotherapy, resulting in no evidence of disease for nine months; she survived for 27 months. Using our technology, the patient experienced an improvement in the quality of life and an increase in survival.

100 Deals associated with Verthermia Acquisition, Inc.

Login to view more data

100 Translational Medicine associated with Verthermia Acquisition, Inc.

Login to view more data